OR52N2
geneOn this page
Summary
OR52N2 (olfactory receptor family 52 subfamily N member 2, HGNC:15228) is a protein-coding gene on chromosome 11p15.4, encoding Olfactory receptor 52N2 (Q8NGI0). Odorant receptor.
Olfactory receptors interact with odorant molecules in the nose, to initiate a neuronal response that triggers the perception of a smell. The olfactory receptor proteins are members of a large family of G-protein-coupled receptors (GPCR) arising from single coding-exon genes. Olfactory receptors share a 7-transmembrane domain structure with many neurotransmitter and hormone receptors and are responsible for the recognition and G protein-mediated transduction of odorant signals. The olfactory receptor gene family is the largest in the genome.
Source: NCBI Gene 390077 — RefSeq curated summary.
At a glance
- GWAS associations: 4
- Clinical variants (ClinVar): 1 total
- MANE Select transcript:
NM_001005174
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:15228 |
| Approved symbol | OR52N2 |
| Name | olfactory receptor family 52 subfamily N member 2 |
| Location | 11p15.4 |
| Locus type | gene with protein product |
| Status | Approved |
| Ensembl gene | ENSG00000180988 |
| Ensembl biotype | protein_coding |
| Entrez | 390077 |
Gene structure
Transcript identifiers
Ensembl transcripts: 3 — 3 protein_coding
ENST00000317037, ENST00000913289, ENST00000913290
RefSeq mRNA: 1 — MANE Select: NM_001005174
NM_001005174
CCDS: CCDS31399
Canonical transcript exons
ENST00000317037 — 2 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001256465 | 5820282 | 5821483 |
| ENSE00003921658 | 5808924 | 5809054 |
Expression profiles
Bgee: expression breadth broad, 33 present calls, max score 83.25.
Top tissues by expression
95 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 83.25 | gold quality |
| granulocyte | CL:0000094 | 44.67 | silver quality |
| islet of Langerhans | UBERON:0000006 | 44.01 | gold quality |
| gall bladder | UBERON:0002110 | 40.08 | gold quality |
| tibial nerve | UBERON:0001323 | 38.91 | gold quality |
| bone marrow cell | CL:0002092 | 38.29 | gold quality |
| apex of heart | UBERON:0002098 | 37.47 | silver quality |
| colonic epithelium | UBERON:0000397 | 37.20 | gold quality |
| ventricular zone | UBERON:0003053 | 36.48 | gold quality |
| cortical plate | UBERON:0005343 | 36.47 | gold quality |
| mucosa of stomach | UBERON:0001199 | 36.39 | silver quality |
| hindlimb stylopod muscle | UBERON:0004252 | 36.16 | silver quality |
| ganglionic eminence | UBERON:0004023 | 35.49 | gold quality |
| bone marrow | UBERON:0002371 | 35.35 | gold quality |
| lymph node | UBERON:0000029 | 33.26 | silver quality |
| right uterine tube | UBERON:0001302 | 33.13 | gold quality |
| prefrontal cortex | UBERON:0000451 | 32.87 | gold quality |
| pancreas | UBERON:0001264 | 32.68 | gold quality |
| fallopian tube | UBERON:0003889 | 32.58 | gold quality |
| subcutaneous adipose tissue | UBERON:0002190 | 32.01 | gold quality |
| spleen | UBERON:0002106 | 31.45 | gold quality |
| tibial artery | UBERON:0007610 | 31.03 | gold quality |
| sural nerve | UBERON:0015488 | 30.93 | gold quality |
| popliteal artery | UBERON:0002250 | 30.92 | gold quality |
| thoracic mammary gland | UBERON:0005200 | 30.69 | silver quality |
| olfactory segment of nasal mucosa | UBERON:0005386 | 30.46 | gold quality |
| superior frontal gyrus | UBERON:0002661 | 30.22 | gold quality |
| placenta | UBERON:0001987 | 29.93 | silver quality |
| stromal cell of endometrium | CL:0002255 | 29.87 | gold quality |
| adipose tissue | UBERON:0001013 | 29.60 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 2.30 |
Regulation
Is transcription factor: no
Cross-species orthologs
7 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Or52n2b | ENSMUSG00000056782 |
| mus_musculus | Or52n2c | ENSMUSG00000057770 |
| mus_musculus | Or52n2 | ENSMUSG00000063582 |
| rattus_norvegicus | Or52n2 | ENSRNOG00000071862 |
| rattus_norvegicus | Or52n2e | ENSRNOG00000077047 |
| rattus_norvegicus | ENSRNOG00000085363 | |
| rattus_norvegicus | Or52n2b | ENSRNOG00000091068 |
Paralogs (51): OR51E2 (ENSG00000167332), OR51B5 (ENSG00000167355), OR51I1 (ENSG00000167359), OR51Q1 (ENSG00000167360), OR52A5 (ENSG00000171944), OR52W1 (ENSG00000175485), OR51B6 (ENSG00000176239), OR51V1 (ENSG00000176742), OR52E2 (ENSG00000176787), OR51L1 (ENSG00000176798), OR51G2 (ENSG00000176893), OR51A7 (ENSG00000176895), OR51T1 (ENSG00000176900), OR51S1 (ENSG00000176922), OR51F2 (ENSG00000176925), OR51E1 (ENSG00000180785), OR56B4 (ENSG00000180919), OR52E4 (ENSG00000180974), OR52N1 (ENSG00000181001), OR52N5 (ENSG00000181009), OR56B2 (ENSG00000181017), OR56B1 (ENSG00000181023), OR52N4 (ENSG00000181074), OR52P1 (ENSG00000181109), OR52D1 (ENSG00000181609), OR52H1 (ENSG00000181616), OR52K2 (ENSG00000181963), OR52A1 (ENSG00000182070), OR51B4 (ENSG00000183251), OR52E8 (ENSG00000183269), OR52L1 (ENSG00000183313), OR51M1 (ENSG00000184698), OR52B6 (ENSG00000187747), OR51I2 (ENSG00000187918), OR52K1 (ENSG00000196778), OR51D1 (ENSG00000197428), OR51C1 (ENSG00000197674), OR52M1 (ENSG00000197790), OR52E6 (ENSG00000205409), OR52J3 (ENSG00000205495)
Protein
Protein identifiers
Olfactory receptor 52N2 — Q8NGI0 (reviewed: Q8NGI0)
Alternative names: Olfactory receptor OR11-57
All UniProt accessions (1): Q8NGI0
UniProt curated annotations — full annotation on UniProt →
Function. Odorant receptor.
Subcellular location. Cell membrane.
Similarity. Belongs to the G-protein coupled receptor 1 family.
RefSeq proteins (1): NP_001005174* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR000276 | GPCR_Rhodpsn | Family |
| IPR000725 | Olfact_rcpt | Family |
| IPR017452 | GPCR_Rhodpsn_7TM | Domain |
| IPR050402 | OR51/52/56-like | Family |
Pfam: PF13853
UniProt features (20 total): topological domain 8, transmembrane region 7, sequence variant 2, chain 1, glycosylation site 1, disulfide bond 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q8NGI0-F1 | 89.62 | 0.74 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Disulfide bonds (1): 99–191
Glycosylation sites (1): 5
Function
Pathways and Gene Ontology
Reactome pathways
1 pathways
| ID | Pathway |
|---|---|
| R-HSA-9752946 | Expression and translocation of olfactory receptors |
MSigDB gene sets: 16 (showing top):
GOBP_SENSORY_PERCEPTION_OF_CHEMICAL_STIMULUS, KEGG_OLFACTORY_TRANSDUCTION, GOBP_DETECTION_OF_STIMULUS, GOBP_SENSORY_PERCEPTION, GOMF_OLFACTORY_RECEPTOR_ACTIVITY, GOMF_TRANSMEMBRANE_SIGNALING_RECEPTOR_ACTIVITY, GOMF_G_PROTEIN_COUPLED_RECEPTOR_ACTIVITY, GOBP_SENSORY_PERCEPTION_OF_SMELL, GOBP_G_PROTEIN_COUPLED_RECEPTOR_SIGNALING_PATHWAY, GOBP_DETECTION_OF_STIMULUS_INVOLVED_IN_SENSORY_PERCEPTION, REACTOME_OLFACTORY_SIGNALING_PATHWAY, REACTOME_SENSORY_PERCEPTION, GOBP_DETECTION_OF_CHEMICAL_STIMULUS, GOMF_MOLECULAR_TRANSDUCER_ACTIVITY, chr11p15
GO Biological Process (5): signal transduction (GO:0007165), G protein-coupled receptor signaling pathway (GO:0007186), sensory perception of smell (GO:0007608), nervous system process (GO:0050877), detection of chemical stimulus involved in sensory perception of smell (GO:0050911)
GO Molecular Function (2): G protein-coupled receptor activity (GO:0004930), olfactory receptor activity (GO:0004984)
GO Cellular Component (2): plasma membrane (GO:0005886), membrane (GO:0016020)
Reactome top-level categories
Rollup of top-1 pathways:
| Category | Pathways |
|---|---|
| Olfactory Signaling Pathway | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| transmembrane signaling receptor activity | 2 |
| cell communication | 1 |
| cellular process | 1 |
| signaling | 1 |
| regulation of cellular process | 1 |
| cellular response to stimulus | 1 |
| G protein-coupled receptor activity | 1 |
| signal transduction | 1 |
| sensory perception of chemical stimulus | 1 |
| system process | 1 |
| sensory perception of smell | 1 |
| detection of chemical stimulus involved in sensory perception | 1 |
| G protein-coupled receptor signaling pathway | 1 |
| detection of chemical stimulus involved in sensory perception of smell | 1 |
| membrane | 1 |
| cell periphery | 1 |
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
92 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| OR52N2 | GPN1 | Q9HCN4 | 544 |
| OR52N2 | LHPP | Q9H008 | 479 |
| OR52N2 | CLPTM1L | Q96KA5 | 419 |
| OR52N2 | LAMC3 | Q9Y6N6 | 403 |
| OR52N2 | MATN4 | O95460 | 356 |
| OR52N2 | FGFR1OP2 | Q9NVK5 | 346 |
| OR52N2 | TRIM5 | Q9C035 | 318 |
| OR52N2 | STK40 | Q8N2I9 | 315 |
| OR52N2 | TUBAL3 | A6NHL2 | 312 |
| OR52N2 | MAGEA6 | P43360 | 290 |
| OR52N2 | SERPINB8 | P50452 | 276 |
| OR52N2 | HLA-DQB1 | P01917 | 269 |
| OR52N2 | ADH1B | P00325 | 250 |
| OR52N2 | PARP15 | Q460N3 | 248 |
| OR52N2 | CCDC121 | Q6ZUS5 | 245 |
IntAct
0 interactions, top by confidence:
ESM2 similar proteins: A0A3B3IT45, A6NGY5, O88628, P0C646, Q6IFG1, Q8NGF0, Q8NGF1, Q8NGF3, Q8NGH6, Q8NGH7, Q8NGH9, Q8NGI0, Q8NGI2, Q8NGJ2, Q8NGJ3, Q8NGJ4, Q8NGJ5, Q8NGJ6, Q8NGJ7, Q8NGJ9, Q8NGK1, Q8NGK2, Q8NGK3, Q8NGK4, Q8NGK5, Q8NGK6, Q8NH53, Q8NH55, Q8NH56, Q8NH57, Q8NH59, Q8NH60, Q8NH61, Q8NH63, Q8NH64, Q8TCB6, Q8VBV9, Q96RD2, Q96RD3, Q9H255
Diamond homologs: A0A3B3IT45, A4D2G3, A6NF89, A6NGY5, A6NL08, A6NL26, A6NMU1, A6NND4, O88628, P0C629, P0C646, P0C7N1, P0C7T3, P23266, P23273, P23274, P30954, Q13606, Q60888, Q62007, Q6IF63, Q6IFG1, Q6W049, Q8NGA6, Q8NGF0, Q8NGF1, Q8NGF3, Q8NGG8, Q8NGH5, Q8NGH6, Q8NGH7, Q8NGH8, Q8NGH9, Q8NGI0, Q8NGI1, Q8NGI2, Q8NGI3, Q8NGI7, Q8NGJ2, Q8NGJ3
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
1 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 0 |
| Likely benign | 0 |
| Benign | 1 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
197 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 11:5820996:ACTAT:A | acceptor_gain | 0.8800 |
| 11:5820996:A:AG | acceptor_gain | 0.8300 |
| 11:5820896:CAAG:C | donor_loss | 0.7200 |
| 11:5820897:AAGG:A | donor_loss | 0.7200 |
| 11:5820898:AG:A | donor_loss | 0.7200 |
| 11:5820900:G:GA | donor_loss | 0.7200 |
| 11:5820901:T:C | donor_loss | 0.7200 |
| 11:5820997:C:G | acceptor_gain | 0.7200 |
| 11:5821000:T:TA | acceptor_gain | 0.7100 |
| 11:5821010:GGCT:G | acceptor_gain | 0.7100 |
| 11:5821009:AG:A | acceptor_gain | 0.6900 |
| 11:5821010:GG:G | acceptor_gain | 0.6900 |
| 11:5820795:A:T | donor_gain | 0.6800 |
| 11:5820902:A:T | donor_loss | 0.6800 |
| 11:5820922:TCA:T | donor_gain | 0.6700 |
| 11:5820923:C:A | donor_gain | 0.6700 |
| 11:5820999:AT:A | acceptor_gain | 0.6700 |
| 11:5821009:A:AG | acceptor_gain | 0.6700 |
| 11:5821010:G:GG | acceptor_gain | 0.6700 |
| 11:5820794:G:GT | donor_gain | 0.6500 |
| 11:5820925:A:G | donor_gain | 0.6500 |
| 11:5820577:C:G | donor_gain | 0.6400 |
| 11:5821000:T:G | acceptor_gain | 0.6400 |
| 11:5820964:T:A | donor_gain | 0.6200 |
| 11:5821005:TTGCA:T | acceptor_loss | 0.6200 |
| 11:5821006:TGCAG:T | acceptor_loss | 0.6200 |
| 11:5821007:GCAG:G | acceptor_loss | 0.6200 |
| 11:5821008:CA:C | acceptor_loss | 0.6200 |
| 11:5820521:C:CG | donor_gain | 0.5900 |
| 11:5820570:AT:A | donor_gain | 0.5800 |
AlphaMissense
2138 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 11:5820695:G:A | M120I | 0.849 |
| 11:5820695:G:C | M120I | 0.849 |
| 11:5820695:G:T | M120I | 0.849 |
| 11:5820645:T:C | F104L | 0.834 |
| 11:5820647:T:A | F104L | 0.834 |
| 11:5820647:T:G | F104L | 0.834 |
| 11:5821049:A:C | K238N | 0.830 |
| 11:5821049:A:T | K238N | 0.830 |
| 11:5820706:G:C | R124P | 0.826 |
| 11:5821003:T:C | I223T | 0.808 |
| 11:5820703:A:T | D123V | 0.801 |
| 11:5820703:A:C | D123A | 0.798 |
| 11:5821240:T:C | I302T | 0.781 |
| 11:5821216:T:A | V294D | 0.768 |
| 11:5820467:C:A | N44K | 0.764 |
| 11:5820467:C:G | N44K | 0.764 |
| 11:5820704:C:A | D123E | 0.761 |
| 11:5820704:C:G | D123E | 0.761 |
| 11:5821011:G:C | A226P | 0.759 |
| 11:5820382:T:C | L16S | 0.748 |
| 11:5820970:A:C | D212A | 0.745 |
| 11:5820435:T:C | C34R | 0.743 |
| 11:5820621:T:C | F96L | 0.741 |
| 11:5820623:T:A | F96L | 0.741 |
| 11:5820623:T:G | F96L | 0.741 |
| 11:5820971:T:A | D212E | 0.740 |
| 11:5820971:T:G | D212E | 0.740 |
| 11:5820797:T:A | N154K | 0.735 |
| 11:5820797:T:G | N154K | 0.735 |
| 11:5821131:T:C | F266L | 0.734 |
dbSNP variants (sampled 300 via entrez): RS1000017003 (11:5811564 A>C), RS1000151819 (11:5820411 C>A,T), RS1000403189 (11:5816302 T>C,G), RS1000753862 (11:5821457 C>A,T), RS1000872282 (11:5810315 G>C,T), RS1000921607 (11:5821427 G>A), RS1000971922 (11:5821751 A>G), RS1000976048 (11:5821813 C>T), RS1001092214 (11:5816064 G>T), RS1001642520 (11:5812582 C>A), RS1001693571 (11:5812854 C>T), RS1001740267 (11:5810962 G>A), RS1001975496 (11:5810676 G>A), RS1002543968 (11:5815694 A>T), RS1002741073 (11:5812258 G>C)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
4 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST003857_3 | Oral cavity and pharyngeal cancer | 5.000000e-08 |
| GCST010725_20 | Malaria | 4.000000e-69 |
| GCST010725_33 | Malaria | 2.000000e-67 |
| GCST010725_51 | Malaria | 1.000000e-55 |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
4 total (human), top 4 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Amiodarone | increases expression | 1 |
| Atrazine | increases expression | 1 |
| Cadmium | increases abundance, decreases expression | 1 |
| Cadmium Chloride | decreases expression, increases abundance | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
- Disease cohort memberships (association, not causation — diseases whose associated-gene cohort lists this gene; a subset are also under Associated diseases): head and neck cancer